Koers Can-Fite BioPharma Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
CANF
IL0010944739
Farmaceutische producten
Omzet 2023 | 743K 2,73 mln. 690K | Omzet 2024 * | 10 mln. 36,75 mln. 9,28 mln. | Marktkapitalisatie | 13,85 mln. 50,91 mln. 12,85 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -7 mln. -25,73 mln. -6,5 mln. | Nettowinst (verlies) 2024 * | - 0 0 | EV/omzet 2023 | 17,6 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 1,39 x |
K/w-verhouding 2023 |
-0,71
x | K/w-verhouding 2024 * |
-
| Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 99,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Motti Farbstein
CEO | Chief Executive Officer | 59 | 01-08-03 |
Pnina Fishman
FOU | Founder | 74 | 11-09-94 |
Ilan Cohn
FOU | Founder | 67 | 11-09-94 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Abraham Sartani
BRD | Director/Board Member | 76 | 01-01-01 |
Ilan Cohn
FOU | Founder | 67 | 11-09-94 |
Pnina Fishman
FOU | Founder | 74 | 11-09-94 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,44% | 90,78 mld. | |
+9,61% | 43,96 mld. | |
-16,67% | 31,34 mld. | |
+44,99% | 23,45 mld. | |
-9,42% | 16,48 mld. | |
-25,92% | 15,03 mld. | |
-9,27% | 12,79 mld. | |
-7,57% | 12,19 mld. | |
+0,07% | 8,5 mld. |